Briollais L - Search Results

1

NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.

Savas S, Azorsa DO, Jarjanazi H, Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH, Briollais L, Ozcelik H, Tuzmen S. Savas S, et al. Among authors: briollais l. PLoS One. 2011 Apr 4;6(4):e18306. doi: 10.1371/journal.pone.0018306. PLoS One. 2011. PMID: 21483694 Free PMC article.

2

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Figueiredo JC, et al. Among authors: briollais l. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):583-91. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066923

3

SNP-SNP interactions in breast cancer susceptibility.

Onay VU, Briollais L, Knight JA, Shi E, Wang Y, Wells S, Li H, Rajendram I, Andrulis IL, Ozcelik H. Onay VU, et al. Among authors: briollais l. BMC Cancer. 2006 May 3;6:114. doi: 10.1186/1471-2407-6-114. BMC Cancer. 2006. PMID: 16672066 Free PMC article.

4

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.

Figueiredo JC, Knight JA, Cho S, Savas S, Onay UV, Briollais L, Goodwin PJ, McLaughlin JR, Andrulis IL, Ozcelik H. Figueiredo JC, et al. Among authors: briollais l. BMC Cancer. 2007 Jun 14;7:99. doi: 10.1186/1471-2407-7-99. BMC Cancer. 2007. PMID: 17567920 Free PMC article.

5

Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario.

Briollais L, Wang Y, Rajendram I, Onay V, Shi E, Knight J, Ozcelik H. Briollais L, et al. BMC Med. 2007 Aug 7;5:22. doi: 10.1186/1741-7015-5-22. BMC Med. 2007. PMID: 17683639 Free PMC article.

6

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk.

Onay UV, Aaltonen K, Briollais L, Knight JA, Pabalan N, Kilpivaara O, Andrulis IL, Blomqvist C, Nevanlinna H, Ozcelik H. Onay UV, et al. Among authors: briollais l. BMC Cancer. 2008 Jan 14;8:6. doi: 10.1186/1471-2407-8-6. BMC Cancer. 2008. PMID: 18194538 Free PMC article.

7

Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.

Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Jarjanazi H, et al. Among authors: briollais l. Hum Mutat. 2008 Apr;29(4):461-7. doi: 10.1002/humu.20732. Hum Mutat. 2008. PMID: 18330920

8

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, Bapat B. Kron K, et al. Among authors: briollais l. PLoS One. 2009;4(3):e4830. doi: 10.1371/journal.pone.0004830. Epub 2009 Mar 13. PLoS One. 2009. PMID: 19283074 Free PMC article.

9

DNA methylation of HOXD3 as a marker of prostate cancer progression.

Kron KJ, Liu L, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L, van der Kwast TH, Bapat B. Kron KJ, et al. Among authors: briollais l. Lab Invest. 2010 Jul;90(7):1060-7. doi: 10.1038/labinvest.2010.57. Epub 2010 Mar 8. Lab Invest. 2010. PMID: 20212450 Free article.

10

A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.

Savas S, Briollais L, Ibrahim-zada I, Jarjanazi H, Choi YH, Musquera M, Fleshner N, Venkateswaran V, Ozcelik H. Savas S, et al. Among authors: briollais l. PLoS One. 2010 Sep 7;5(9):e12601. doi: 10.1371/journal.pone.0012601. PLoS One. 2010. PMID: 20830292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters